Newfound hormone holds hope for diabetes treatment
|
1
|
Mannkind
|
Apr 25, 2013 05:10PM
|
Re: Quantifying Dilution Risk
|
1
|
Mannkind
|
Sep 05, 2012 10:00AM
|
Re: On a lighter note
|
1
|
Mannkind
|
Sep 09, 2012 10:21PM
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i
|
1
|
Mannkind
|
Mar 17, 2013 04:47PM
|
Re: MannKind Corp. (MNKD) to Release Earnings on Friday
|
1
|
Mannkind
|
Aug 09, 2013 09:09AM
|
Re: Warrants/dilution/ch... in share price
|
1
|
Mannkind
|
May 01, 2013 09:13PM
|
Re: Share Price (simplified calculation)
|
1
|
Mannkind
|
May 27, 2013 08:22AM
|
Re: Anyone remember the thread on Current and Projected Share Count
|
1
|
Mannkind
|
Jul 10, 2013 04:18PM
|
Re: Cowen and Company
|
1
|
Mannkind
|
Feb 20, 2013 02:25PM
|
Re: Opko Health: Setting Up For A Big Short Squeeze?
|
1
|
Mannkind
|
Oct 03, 2012 10:17AM
|
5 Reasons MannKind Could Be The Best Performing Stock Of 2013
|
1
|
Mannkind
|
Mar 08, 2013 07:43AM
|
Re: Valuations
|
1
|
Mannkind
|
Nov 12, 2012 12:38PM
|
Re: According to Al:
|
1
|
Mannkind
|
Jan 10, 2013 08:09PM
|
European Regulator Finds Little Risk in Diabetes Drugs
|
1
|
Mannkind
|
Jul 28, 2013 06:01AM
|
NYTimes: High Blood Sugar Linked to Dementia
|
1
|
Mannkind
|
Aug 12, 2013 08:39PM
|
Re: trial results
|
1
|
Mannkind
|
Aug 12, 2013 08:45PM
|
Pricing MannKind Corporation On A Stand-Alone Basis
|
1
|
Mannkind
|
Jun 12, 2013 09:16AM
|
Re: Updated Share Price Model
|
1
|
Mannkind
|
Feb 19, 2013 09:26PM
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i
|
1
|
Mannkind
|
Mar 17, 2013 07:35PM
|
Re: JPMorgan Healthcare Conference Highlights: MannKind
|
1
|
Mannkind
|
Jan 11, 2013 01:21PM
|